A local doctor expressed his enthusiasm that the reimbursement of Pfizer Korea's Ngenla (ingredient: Somatropin), a once-weekly growth hormone drug, will enhance compliance among adolescent patients.At a press conference held to mark the reimbursement at the Koreana Hotel in Seoul on Thursday, Profe
Hanmi Pharm has suggested that the company could develop HM15912, its short bowel syndrome treatment candidate developed as a once-monthly dosage form, as a treatment for another rare disease, graft-versus-host disease (GVHD).Hanmi said Thursday that it presented two posters on the research results
SINGAPORE -- The International Association for the Study of Lung Cancer 2023 World Congress of Lung Cancer (IASLC 2023 WCLC), held Sept. 9-12 in Singapore, featured many milestone studies in treating lung cancer.AstraZeneca showed a particularly remarkable performance.Its Tagrisso (osimertinib), a t
CHA Vaccine Institute said on Thursday it has obtained a Canadian patent for its Lipo-pam immune enhancer, recognizing it as an adjuvant for vaccines that include a liposome with the lipopeptide as the active ingredient.The patent covers both the vaccine and the associated method for manufacturing v
Gilead Sciences said it has appointed Choi Jae-yeon, the former Managing Director of MSD Taiwan, as the new general manager of its Korea offshoot.Choi will oversee Gilead's operations in Korea, with a focus on developing business in areas such as HIV, viral hepatitis, Covid-19, antifungal treatments
Korean pharmaceutical companies have received a heap of administrative penalties from the Ministry of Food and Drug Safety (MFDS), causing a stir.On Monday, GC Wellbeing, a subsidiary of the GC Group, received a one-month suspension of manufacturing four specialized drugs from the MFDS. As a result,
Hanmi Science said on Wednesday that it plans to pursue obesity management as a strong growth engine to build a unique portfolio called, the "Hanmi Obesity Pipeline (H.O.P)."Recently, Danish biotech company Novo Nordisk has gained significant media attention for its weight loss drug, Wegovy (ingredi
AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, said Wednesday it has signed a memorandum of understanding for strategic collaboration with Shanghai Pharmaceuticals, the second-largest pharmaceutical distributor in China.The main contents of the MOU inc
Samsung Biologics said on Wednesday that Samsung Life Science Fund made an equity investment in AIMEDBIO, a domestic company specializing in therapeutic solutions for neuro-oncological and neuro-degenerative diseases.This marks the fund’s fourth investment after previous investments in foreign compa
VaxCell Biotherapeutics said it reported an impressive disease control rate (DCR) of “100 percent” for combination therapy using VAX-NK, its hepatocellular carcinoma (HCC) treatment candidate, and hepatic arterial infusion chemotherapy (HAIC), from its phase 2a trial.Speaking at a press conference a
The Seoul Administrative Court has set a date for the verdict in the lawsuit between the Ministry of Food and Drug Safety (MFDS) and PharmaResearchBio regarding the latter's claims to cancel the MFDS' order to recall, destroy, and halt its botulinum toxin (BTX) product.The court will make the ruling
Kolmar Korea Corp. said it has emerged victorious in a trade secret infringement lawsuit against the Korean subsidiary of the Italian cosmetics company, Intercos.The Seoul Central District Court ruled in favor of Kolmar Korea in the lawsuit against Intercos Korea and some former researchers for brea
HK inno.N has partnered with Dong-A ST to develop a next-generation non-small cell lung cancer (NSCLC) treatment. The company announced its ambition to develop a fifth-generation NSCLC treatment through protein degradation, going beyond epithelial growth factor receptor (EGFR) inhibitors.HK inno.N s
Novelty Nobility, a biotech specializing in antibody drug discovery, said on Monday that it launched the PREXISE-D Order-to-Discovery Solution (OTD Solution), a fully humanized mouse antibody discovery service for pharmaceutical companies in Korea. Novelty Nobility's PREXISE-D is a fit-for-purpose a
SK bioscience said on Friday that it signed a memorandum of understanding (MOU) with the Serbian government and Frontier Biopharma to develop the vaccine manufacturing environment in Serbia.Consequently, SK bioscience and Frontier Biopharma also agreed to sign a contract within the year to establish
Recent data indicates that phentermine, often referred to as a weight loss pill, has been the most reported drug for side effects among obesity treatments prescribed in Korea.Such data was confirmed through a joint study conducted by Kyung Hee University's School of Pharmacy and Ajou University's Sc
AstraZeneca Korea's lung cancer drug Tagrisso (osimertinib) has passed the Drug Reimbursement Evaluation Committee, taking a step closer to expanded coverage for first-line lung cancer treatment.The Health Insurance Review and Assessment Service (HIRA) held the 10th committee meeting on Thursday and
Aptose Biosciences, the U.S. partner of Hanmi Pharm in the development of HM43239, an acute myeloid leukemia (AML) treatment candidate containing tuspetinib, has announced the successful completion of a $3 million investment from Hanmi in the form of common shares in the company.According to Aptose,
Korea United Pharm said it has signed a five-year supply and distribution agreement with MCQ, a Thai-based pharmaceutical company specializing in drug distribution, for Levotics CR Tab., a mucoactive drug.Levotics CR Tab. is an incrementally modified drug (IMD) that improves compliance and convenien
Some Korean biopharmaceutical companies, including LG Chem, Hanmi Pharmaceutical, and Daewoong Bio, are considering introducing the continuous manufacturing (CM) process, attracting the industry’s attention.Unlike the existing “batch-type” production, continuous manufacturing (CM) is a method of man